{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:57:23Z","timestamp":1777309043167,"version":"3.51.4"},"reference-count":22,"publisher":"Academy of Managed Care Pharmacy","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.18553\/jmcp.2026.32.5.563","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:24:11Z","timestamp":1777307051000},"page":"563-573","source":"Crossref","is-referenced-by-count":0,"title":["Patient out-of-pocket costs and rheumatology biosimilar competition"],"prefix":"10.18553","volume":"32","author":[{"given":"Victoria W.","family":"Dayer","sequence":"first","affiliation":[{"name":"CHOICE Institute, School of Pharmacy, University of Washington, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan N.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmacy, University of Washington, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Roth","sequence":"additional","affiliation":[{"name":"CHOICE Institute, School of Pharmacy, University of Washington, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireia","family":"Jofre-Bonet","sequence":"additional","affiliation":[{"name":"Office of Health Economics, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean D.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"CHOICE Institute, School of Pharmacy, University of Washington, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"r1","unstructured":"IQVIA.\n                      Assessing the Biosimilar Void in the US\n                      . IQVIA Institute for Human Data Science; 2025. Accessed February 3, 2025. https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports-and-publications\/reports\/assessing-the-biosimilar-void-in-the-us"},{"key":"r2","unstructured":"Center for Drug Evaluation and Research. Commemorating the 15th anniversary of the Biologics Price Competition and Innovation Act. US Food and Drug Administration. Published March 26, 2025. Accessed October 15, 2025. https:\/\/www.fda.gov\/drugs\/cder-conversations\/commemorating-15th-anniversary-biologics-price-competition-and-innovation-act"},{"key":"r3","unstructured":"Association for Accessible Medicines.\n                      The U.S. Generic & Biosimilar Medicines Savings Report: September 2025\n                      . AAM; 2025. Accessed September 18, 2025. https:\/\/accessiblemeds.org\/wp-content\/uploads\/2025\/09\/AAM-2025-Generic-Biosimilar-Medicines-Savings-Report-WEB.pdf"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.24104"},{"key":"r5","unstructured":"IQVIA.\n                      Biosimilars in the United States 2023\u20132027.\n                      IQVIA Institute for Human Data Science; 2023. Accessed February 15, 2024. https:\/\/www.iqvia.com\/insights\/the-iqvia-institute\/reports-and-publications\/reports\/biosimilars-in-the-united-states-2023-2027"},{"key":"r6","unstructured":"Maxwell, A. Biosimilars have lowered costs for Medicare Part B and enrollees, but opportunities for substantial spending reductions still exist. U.S. Department of Health and Human Services, Office of Inspector General. Published September 2023. Accessed July 23, 2024. https:\/\/oig.hhs.gov\/reports-and-publications\/all-reports-and-publications\/biosimilars-have-lowered-costs-for-medicare-part-b-and-enrollees-but-opportunities-for-substantial-spending-reductions-still-exist\/"},{"issue":"1","key":"r7","volume":"29","author":"Fusco N","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.5429"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.06.014"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.7.795"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2763"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jeconom.2020.12.001"},{"key":"r13","unstructured":"Centers for Medicare & Medicaid Services. ASP pricing files. Accessed February 11, 2025. https:\/\/www.cms.gov\/medicare\/payment\/part-b-drugs\/asp-pricing-files"},{"key":"r14","unstructured":"Micromedex. Accessed February 11, 2025. http:\/\/www.micromedexsolutions.com"},{"key":"r15","doi-asserted-by":"crossref","unstructured":"US Bureau of Labor Statistics. Consumer Price Index (CPI) databases. Accessed June 1, 2025. https:\/\/www.bls.gov\/cpi\/data.htm","DOI":"10.69645\/DSDC8304"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2025.02.008"},{"key":"r17","unstructured":"Callaway B, Sant\u2019Anna PHC. Getting started with the did package. GitHub. Accessed September 27, 2024. https:\/\/bcallaway11.github.io\/did\/articles\/did-basics.html"},{"key":"r18","doi-asserted-by":"publisher","DOI":"10.1257\/aeri.20210236"},{"key":"r19","unstructured":"Bilinski A, Hatfield LA. Nothing to see here? Non-inferiority approaches to parallel trends and other model assumptions.\n                      arXiv\n                      . Preprint posted online January 17, 2020. doi:10.48550\/arXiv.1805.03273"},{"key":"r20","unstructured":"Bosworth A, Sheingold S, Finegold K, De Lew N, Sommers BD. Price increases for prescription drugs, 2016-2022. ASPE Office of Health Policy. Published September 30, 2022. Accessed November 5, 2025. https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/e9d5bb190056eb94483b774b53d512b4\/price-tracking-brief.pdf"},{"key":"r21","unstructured":"Trish E, Blaylock B. Shifting cost-sharing burden to beneficiaries in Medicare Part D. USC Leonard D. Schaeffer Institute for Public Policy & Government Service. Published June 19, 2025. Accessed October 30, 2025. https:\/\/schaeffer.usc.edu\/research\/cost-sharing-burden-medicare-part-d\/"},{"key":"r22","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.3964"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:24:36Z","timestamp":1777307076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2026.32.5.563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.18553\/jmcp.2026.32.5.563"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2026.32.5.563","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}